Mitogen-activated protein kinase p38-2 and methods of use therefor
CA 2255579 A1 · Owner: Belardetti, Francesco · Inventors: Cobb, Melanie; Yang, Maria X.H.; Belardetti, Francesco
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compositions and methods are provided for the treatment of conditions associated with mitogen-activated protein kinase cascades. In particular the , mitogen-activated protein kinase p38-2 and polypeptide variants thereof that stimulate phosphorylation and activation of substrates such as ATF2 are , provided. The polypeptides may be used for example, to identify antibodies , and other agents that inhibit signal transduction via the p38-2 kinase cascade. The polypeptides and agents may be used in a variety of methods such , as in the reduction of pain sensations.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 20, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 20, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 20, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.